Development of Therapeutic Vaccines for Ovarian Cancer

Ovarian cancer remains the deadliest of all gynecologic malignancies. Our expanding knowledge of ovarian cancer immunology has allowed the development of therapies that generate systemic anti-tumor immune responses. Current immunotherapeutic strategies include immune checkpoint blockade, cellular th...

Descripción completa

Detalles Bibliográficos
Autores principales: Chow, Stephanie, Berek, Jonathan S., Dorigo, Oliver
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7711901/
https://www.ncbi.nlm.nih.gov/pubmed/33167428
http://dx.doi.org/10.3390/vaccines8040657

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7711901/
https://www.ncbi.nlm.nih.gov/pubmed/33167428
http://dx.doi.org/10.3390/vaccines8040657

Ejemplares similares